Aggregation kinetics of low density lipoproteins upon exposure to sphingomyelinase

Journal of Colloid and Interface Science
Andrew J GuarinoSteven P Wrenn

Abstract

The response-to-retention hypothesis in atherosclerosis states that subendothelial retention of cholesterol-rich, atherogenic lipoproteins is the central pathogenic event that is both necessary and sufficient to provoke lesion initiation in an otherwise normal artery. Sphingomyelinase-induced aggregation of low density lipoproteins (LDL) is known to facilitate LDL retention, and the only available measurements of LDL aggregates suggest LDL aggregate size is approximately 100 nm. This study investigates the hypothesis that LDL aggregate size is determined by the relative rates of sphingomyelinase hydrolysis and LDL collisions. Using a combination of dynamic light scattering and UV-vis absorbance spectroscopy to measure aggregation kinetics and particle sizes, a mass action model was developed to describe the aggregation process. It is found that LDL aggregation is sensitive to the relative amounts of sphingomyelinase and LDL and to pH. Model rate parameters were fit to experimental data in vitro and used to predict LDL aggregate sizes in vivo. The value of 100 nm in vivo does not appear to be fixed; rather, it is the value expected for the prevailing enzyme-to-LDL molar ratio.

References

May 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·U P Steinbrecher, M Lougheed
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A G SuitsJ W Heinecke
Mar 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·D M Small
Jul 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J C KhooD Steinberg
Jan 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·I TabasA R Tall
May 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·K J Williams, I Tabas
Jun 1, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·E Hurt-CamejoG Camejo
Nov 13, 1998·Current Opinion in Lipidology·K J Williams, I Tabas
Dec 2, 1998·Journal of Biochemistry·S FujiiK Ikeda
Oct 26, 2000·Current Opinion in Lipidology·E Hurt-CamejoP Sartipy
Aug 18, 2001·Circulation Research·E Hurt-CamejoP Kovanen
Jul 30, 2002·Science·Kevin Jon Williams, Ira Tabas

❮ Previous
Next ❯

Citations

Apr 6, 2006·Chemistry and Physics of Lipids·Andrew J GuarinoSteven P Wrenn
Jul 16, 2005·Journal of Colloid and Interface Science·Andrew J GuarinoSteven P Wrenn
Aug 2, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Michael J Walters, Steven P Wrenn

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.